|
An initial event notification was received by united therapeutics drug safety on (b)(6) 2026 from accredo specialty pharmacy, and forwarded to millyard advanced medical products, llc, on (b)(6) 2026.It was reported that the patient received pump failure alarms while using both of their remunitypro pumps, serial numbers (b)(6).The patient experienced an interruption in therapy but denied any adverse side effects.It was further reported that after performing a cassette change for pump (b)(6), the patient was able to restart their infusion; however, they were unable to titrate up to the correct delivery rate as they had forgotten their system passcode.The patient's caregiver later reported that the patient had been admitted to the hospital for evaluation and medical management as they had been off remodulin for an extended period of time.Replacement systems were sent to the patient by the specialty pharmacy.
|
|
Investigation into the reported event remains ongoing and a supplemental report will be filed once results are available.No additional information relevant to the reported event has been made available to millyard advanced medical products, llc, for further investigation.
|